FR2361104A2 - Medicament sous forme de grains friables - Google Patents

Medicament sous forme de grains friables

Info

Publication number
FR2361104A2
FR2361104A2 FR7701501A FR7701501A FR2361104A2 FR 2361104 A2 FR2361104 A2 FR 2361104A2 FR 7701501 A FR7701501 A FR 7701501A FR 7701501 A FR7701501 A FR 7701501A FR 2361104 A2 FR2361104 A2 FR 2361104A2
Authority
FR
France
Prior art keywords
granules
tablets
inhalation
esp
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7701501A
Other languages
English (en)
French (fr)
Other versions
FR2361104B2 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB260676A external-priority patent/GB1569611A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2361104A2 publication Critical patent/FR2361104A2/fr
Application granted granted Critical
Publication of FR2361104B2 publication Critical patent/FR2361104B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7701501A 1976-01-23 1977-01-20 Medicament sous forme de grains friables Granted FR2361104A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB260676A GB1569611A (en) 1976-01-23 1976-01-23 Pelletised or granular medicament formulation
GB260876 1976-01-23

Publications (2)

Publication Number Publication Date
FR2361104A2 true FR2361104A2 (fr) 1978-03-10
FR2361104B2 FR2361104B2 (enrdf_load_stackoverflow) 1982-09-17

Family

ID=26237614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701501A Granted FR2361104A2 (fr) 1976-01-23 1977-01-20 Medicament sous forme de grains friables

Country Status (12)

Country Link
JP (1) JPS5294413A (enrdf_load_stackoverflow)
AU (1) AU506878B2 (enrdf_load_stackoverflow)
CA (1) CA1116516A (enrdf_load_stackoverflow)
DK (1) DK27177A (enrdf_load_stackoverflow)
ES (1) ES455273A1 (enrdf_load_stackoverflow)
FI (1) FI67663C (enrdf_load_stackoverflow)
FR (1) FR2361104A2 (enrdf_load_stackoverflow)
IE (1) IE45260B1 (enrdf_load_stackoverflow)
LU (1) LU76618A1 (enrdf_load_stackoverflow)
NO (1) NO148542C (enrdf_load_stackoverflow)
SE (1) SE442950B (enrdf_load_stackoverflow)
ZA (1) ZA77327B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12161605B2 (en) 2016-12-08 2024-12-10 R.P. Scherer Technologies, Llc Method to relieve stress in capsule shells to reduce propensity to break

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12161605B2 (en) 2016-12-08 2024-12-10 R.P. Scherer Technologies, Llc Method to relieve stress in capsule shells to reduce propensity to break

Also Published As

Publication number Publication date
ZA77327B (en) 1977-12-28
ES455273A1 (es) 1978-04-01
FI67663C (fi) 1985-05-10
DK27177A (da) 1977-07-24
NO148542B (no) 1983-07-25
FI770070A7 (enrdf_load_stackoverflow) 1977-07-24
IE45260L (en) 1977-07-23
NO770198L (no) 1977-07-26
AU506878B2 (en) 1980-01-24
SE7700665L (sv) 1977-07-24
AU2158977A (en) 1978-08-03
CA1116516A (en) 1982-01-19
FI67663B (fi) 1985-01-31
LU76618A1 (enrdf_load_stackoverflow) 1977-08-12
FR2361104B2 (enrdf_load_stackoverflow) 1982-09-17
NO148542C (no) 1983-11-02
SE442950B (sv) 1986-02-10
IE45260B1 (en) 1982-07-28
JPS5294413A (en) 1977-08-09
JPS6228124B2 (enrdf_load_stackoverflow) 1987-06-18

Similar Documents

Publication Publication Date Title
CA2131285C (en) Pharmaceutical inhalation compositions
IE41586L (en) Pelletised medicament formulations
US4009280A (en) Powder composition for inhalation therapy
KR840000226A (ko) 신규한 형태의 의약품의 제조방법
EP0361845A3 (en) Medication delivery system
CA2290538A1 (en) Composition comprising finely divided, crystalline particles of budesonide
CA2195065A1 (en) Inhalation composition
BG108517A (en) Dry powder inhalation system for transpulmonary administration
FI843349A0 (fi) Foerfarande foer framstaellning av granulat.
PH27594A (en) Medicaments for the treatment of asthma and other respiratory disorders
FR2361104A2 (fr) Medicament sous forme de grains friables
DE69008107D1 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
CA2277891A1 (en) New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
DE68901102D1 (de) Binde- und verduennungsmittel auf xylitbasis sowie verfahren zu dessen herstellung.
Dautrebande et al. Studies on aerosols V. Effect of dust and pneumodilating aerosols on lung volume and type of respiration in man
Groth et al. Optimal inhalation procedure for the fenoterol powder inhaler
JPH08504338A (ja) 吸入装置
Slabý Morphogenesis of the nasal capsule, the epithelial nasal tube and the organ of Jacobson in Sauropsida. VII. Morphogenesis and phylogenetic morphology of the nasal apparatus in Calotes jubatus O. B
ATE17441T1 (de) Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend.
JPH0137369B2 (enrdf_load_stackoverflow)
US4238502A (en) Method of treating psychiatric conditions
MERCER Production and characterization of aerosols(Production and use of aerosols in treating respiratory tract disorders)
LeFrock et al. Bacillus anthracis and other Bacillus species.
MD3823588T2 (ro) Compoziție farmaceutică sub forma unei tablete masticabile de diosmină sau de fracțiune flavonoidă cuprinzând diosmină
ES413624A3 (es) Un metodo para preparar una composicion farmaceutica en polvo facilmente fluidizable, prevista especialmente para eltratamiento por inhalacion de enfermedades alergicas de las vias respiratorias.

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name